The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quattrocchi, E.
Right arrow Articles by Feldmann, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quattrocchi, E.
Right arrow Articles by Feldmann, M.
The Journal of Immunology, 1999, 163: 1000-1009.
Copyright © 1999 by The American Association of Immunologists

Paradoxical Effects of Adenovirus-Mediated Blockade of TNF Activity in Murine Collagen-Induced Arthritis1

Emilia Quattrocchi*, Marita Walmsley2,*, Kylie Browne3,*, Richard O. Williams*, Lilia Marinova-Mutafchieva*, Wim Buurman{dagger}, Debra M. Butler* and Marc Feldmann4,*

* Kennedy Institute of Rheumatology, London, United Kingdom; and {dagger} Department of Surgery, University of Limburg, Maastricht, The Netherlands

Collagen-induced arthritis (CIA) is an experimental model of arthritis widely used to dissect the pathogenesis of human rheumatoid arthritis and to identify potential therapeutic targets. Among these, TNF-{alpha} has been recognized to play an important role. Here we investigate the feasibility and therapeutic efficacy of prolonged blockade of TNF-{alpha} activity through the adenovirus-mediated gene delivery of a dimeric chimeric human p55 TNFR-IgG fusion protein and compare it to protein therapy in established CIA. A single i.v. administration of the replication-deficient adenovirus yielded microgram serum levels of the chimeric fusion protein and ameliorated CIA for 10 days. Subsequently, benefit was lost and a rebound to greater inflammatory activity was observed despite the continual presence of bioactive TNFR fusion protein. A similar trend was also observed in mice injected directly with comparable amounts of a human TNFR-IgG fusion protein, whereas the administration of a control adenovirus-encoding ß-galactosidase or of a control human IgG1 protein did not significantly affect the disease course. The mechanisms of the rebound of CIA were investigated, and augmented Ab response to collagen type II and TNFR were identified as potential causes. Our results confirm the feasibility of adenovirus-mediated gene delivery of cytokine inhibitors in animal models of autoimmune diseases for investigational purposes and highlight the importance of prolonged studies. Further investigations are needed to optimize ways of exploiting the potential of adenoviral gene therapy in RA.




This article has been cited by other articles:


Home page
Ann Rheum DisHome page
J Adriaansen, M Khoury, C J de Cortie, F J Fallaux, P Bigey, D Scherman, D J Gould, Y Chernajovsky, F Apparailly, C Jorgensen, et al.
Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent
Ann Rheum Dis, September 1, 2007; 66(9): 1143 - 1150.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
P Mukherjee, S-Y Yang, B Wu, Z Song, L K Myers, P D Robbins, and P H Wooley
Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice
Ann Rheum Dis, November 1, 2005; 64(11): 1550 - 1556.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
P Mukherjee, B Wu, L Mayton, S-H Kim, P D Robbins, and P H Wooley
TNF receptor gene therapy results in suppression of IgG2a anticollagen antibody in collagen induced arthritis
Ann Rheum Dis, August 1, 2003; 62(8): 707 - 714.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
L. M. Childs, J. J. Goater, R. J. O'Keefe, and E. M. Schwarz
Effect of Anti-Tumor Necrosis Factor-{alpha} Gene Therapy on Wear Debris-Induced Osteolysis
J. Bone Joint Surg. Am., December 1, 2001; 83(12): 1789 - 1797.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
E. A. Burton, J. B. Wechuck, S. K. Wendell, W. F. Goins, D. J. Fink, and J. C. Glorioso
Multiple Applications For Replication-Defective Herpes Simplex Virus Vectors
Stem Cells, September 1, 2001; 19(5): 358 - 377.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Quattrocchi, M. J. Dallman, A. P. Dhillon, A. Quaglia, G. Bagnato, and M. Feldmann
Murine IL-10 Gene Transfer Inhibits Established Collagen-Induced Arthritis and Reduces Adenovirus-Mediated Inflammatory Responses in Mouse Liver
J. Immunol., May 15, 2001; 166(10): 5970 - 5978.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
G. Kassiotis and G. Kollias
Uncoupling the Proinflammatory from the Immunosuppressive Properties of Tumor Necrosis Factor (TNF) at the p55 TNF Receptor Level: Implications for Pathogenesis and Therapy of Autoimmune Demyelination
J. Exp. Med., February 12, 2001; 193(4): 427 - 434.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K.-N. Kim, S. Watanabe, Y. Ma, S. Thornton, E. H. Giannini, and R. Hirsch
Viral IL-10 and Soluble TNF Receptor Act Synergistically to Inhibit Collagen-Induced Arthritis Following Adenovirus- Mediated Gene Transfer
J. Immunol., February 1, 2000; 164(3): 1576 - 1581.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.